Follow on Google News News By Location Country(s) Industry News
Follow on Google News | ORGANOBALANCE Announces Substantial InvestmentDr Bernd Wegener to invest in Berlin (Germany) Biotech company
Dr Wegener's investment (the extent of which, as agreed between the parties, shall not be disclosed), his extensive experience, expertise and numerous contacts within the pharmaceutical and biotech industries, shall substantially promote and shape the continued successful development of ORGANOBALANCE GmbH. “We are truly delighted that an expert of Dr. Wegener’s immense scientific distinction and experience will join our team at ORGANOBALANCE.” Dr Wegener also envisages excellent prospects for their collaboration, commenting that "With innovative, patentable microorganisms and their active principles, we will be able to develop new diagnostic and therapeutic concepts and procedures particularly for hitherto inadequately treatable indications. I am very much looking forward to working with Professor Lang and ORGANOBALANCE, a leading company in this field, and opening up this as yet untapped potential". About ORGANOBALANCE ORGANOBALANCE GmbH is a company specialising in strain development and microbiological screening. ORGANOBALANCE taps the potential of beneficial microorganisms, known as specific probiotic cultures, in order to counteract, in a natural way, imbalances in the microflora, thus restoring the microbial equilibrium. In close cooperation with renowned industry partners, ORGANOBALANCE develops new biological products in the fields of pharmaceutics, preventive health care, nutrition and cosmetics. In its development activities the company draws on its own collection of microorganisms suitable for use in foodstuffs as well as its own OASSYS® screening systems. ORGANOBALANCE was founded in 2001 and is based in Berlin (Germany). More information can be found at the company´s website. About Dr Wegener Bernd Wegener, DVM, has extensive managerial experience from diverse areas of responsibility in the pharmaceutical industry and relevant associations. After holding positions at Boehringer Ingelheim KG, Degussa Pharmagruppe, Marion Merrell Dow GmbH and Henning Berlin GmbH, he was Founder and Chairman of the Board of the B•R•A•H• Dr Wegener is also Chairman of the Board of the German Federal Association of the Pharmaceutical Industry (BPI) as well as being a member of the board of various associations and supervisory boards. All product and company names mentioned herein are possibly protected, and the property of ORGANOBALANCE GmbH or other companies. For further information please contact: ORGANOBALANCE GmbH Mrs Kristin Ebert Gustav-Meyer- 13355 Berlin Germany Tel.: +49 30 46307-200 Fax: +49 30 46307-210 Email: info@organobalance.com Internet: www.organobalance.com # # # German marketing and PR agency, helping you to place your information, products, and services on German and world wide markets. End
Account Email Address Account Phone Number Disclaimer Report Abuse
|
|